Eli Lilly AMAM
There’s life beyond your Crohn’s disease.
If you have moderate to severe Crohn’s disease, the VIVID-1 study may be of interest to you. This study is researching whether an investigational medication can reduce the symptoms of Crohn’s disease.
You may be able to take part if you:
- Are between 18 and 80 years of age (inclusive)
- Have been diagnosed with Crohn’s disease for at least three months
The study will last 1 year and 5 months. About 1,100 people from up to 36 countries around the world will participate. Study-related care will be provided at no cost